This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Franchitto, A. Articles by Pichierri, P. Search for Related Content PubMed PubMed Citation Articles by Franchitto, A. Articles by Pichierri, P.

The G₂-phase Decatenation Checkpoint Is Defective in Werner Syndrome Cells^{1 ,, 2}

CNRS UPR2169 Instabilité Génétique et Cancer, Institut Gustave Roussy, 94805 Villejuif, France [A. F., P. P.], and Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98195-7470 [J. O.]

It has been proposed that cells monitor chromatid catenation status after DNA replication and inhibit progression into mitosis until chromatids are correctly decatenated by topoisomerase II (TopoII). Studies in yeast have suggested that TopoII may interact with RecQ helicases during this process. Using ICRF187, a TopoII catalytic inhibitor that prevents chromatid decatenation without producing DNA strand breaks, we demonstrated that cells deficient of WRN, a human RecQ helicase, displayed a defect in decatenation checkpoint activation, which was corrected by ectopic expression of wild-type WRN. We also provide evidence that BRCA1 is phosphorylated in an ATR-dependent manner in response to decatenation checkpoint activation and that this phosphorylation is not detectable in Werner syndrome cells. Furthermore, ICRF187 treatment resulted in coimmunoprecipitation of WRN and TopoII. Finally, we demonstrated that override of the decatenation checkpoint resulted in enhanced chromosomal damage and apoptosis only in the absence of WRN, but not in normal cells. Our findings suggest that WRN plays a role in the activation of G₂ decatenation checkpoint and that the abortive function of this pathway itself does not appear to be sufficient to cause genomic instability but rather predisposes to genomic instability and apoptotic cell death in the absence of other "caretaker" genes, such as WRN.

This article has been cited by other articles:

				J. L. Parish, J. Rosa, X. Wang, J. M. Lahti, S. J. Doxsey, and E. J. Androphy The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells J. Cell Sci., December 1, 2006; 119(23): 4857 - 4865. [Abstract] [Full Text] [PDF]

				W.-H. Cheng, R. Kusumoto, P. L. Opresko, X. Sui, S. Huang, M. L. Nicolette, T. T. Paull, J. Campisi, M. Seidman, and V. A. Bohr Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res., January 1, 2006; 34(9): 2751 - 2760. [Abstract] [Full Text] [PDF]

				R. V. Skibbens Unzipped and loaded: the role of DNA helicases and RFC clamp-loading complexes in sister chromatid cohesion J. Cell Biol., June 20, 2005; 169(6): 841 - 846. [Abstract] [Full Text] [PDF]

				T. Nakagawa, Y. Hayashita, K. Maeno, A. Masuda, N. Sugito, H. Osada, K. Yanagisawa, H. Ebi, K. Shimokata, and T. Takahashi Identification of Decatenation G2 Checkpoint Impairment Independently of DNA Damage G2 Checkpoint in Human Lung Cancer Cell Lines Cancer Res., July 15, 2004; 64(14): 4826 - 4832. [Abstract] [Full Text] [PDF]

				S.-J. Lee, J.-S. Yook, S. M. Han, and H.-S. Koo A Werner syndrome protein homolog affects C. elegans development, growth rate, life span and sensitivity to DNA damage by acting at a DNA damage checkpoint Development, June 1, 2004; 131(11): 2565 - 2575. [Abstract] [Full Text] [PDF]

				S. C. Doherty, S. R. McKeown, V. McKelvey-Martin, C. S. Downes, A. Atala, J. J. Yoo, D. A. Simpson, and W. K. Kaufmann Cell Cycle Checkpoint Function in Bladder Cancer J Natl Cancer Inst, December 17, 2003; 95(24): 1859 - 1868. [Abstract] [Full Text] [PDF]